{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T03:12:37Z","timestamp":1771038757199,"version":"3.50.1"},"reference-count":15,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1111\/bjh.70237","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T06:59:26Z","timestamp":1763449166000},"page":"312-316","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A matching\u2010adjusted indirect comparison of survival outcomes with pirtobrutinib (\n                    <scp>BRUIN<\/scp>\n                    ) versus standard of care (\n                    <scp>SCHOLAR<\/scp>\n                    \u20102) in relapsed\/refractory mantle cell lymphoma previously treated with a covalent Bruton tyrosine kinase inhibitor"],"prefix":"10.1111","volume":"208","author":[{"given":"Georg","family":"He\u00df","sequence":"first","affiliation":[{"name":"Department of Hematology and Medical Oncology University Medical School of the Johannes Gutenberg\u2010University  Mainz Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6631-9749","authenticated-orcid":false,"given":"Toby A.","family":"Eyre","sequence":"additional","affiliation":[{"name":"Department of Haematology, Cancer and Haematology Centre Oxford University Hospitals NHS Foundation Trust  Oxford UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min\u2010Hua","family":"Jen","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company Ltd.  Indianapolis Indiana USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiewen","family":"Zhang","sequence":"additional","affiliation":[{"name":"TechData Service Company  King of Prussia Pennsylvania USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Goebel","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company Ltd.  Indianapolis Indiana USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarang","family":"Abhyankar","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company Ltd.  Indianapolis Indiana USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Dreyling","sequence":"additional","affiliation":[{"name":"Medizinische Klinik III, LMU Klinikum  Munich Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"e_1_2_2_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26523"},{"key":"e_1_2_2_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19131"},{"key":"e_1_2_2_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023022353"},{"key":"e_1_2_2_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102015\u201010\u2010673145"},{"key":"e_1_2_2_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018028761"},{"key":"e_1_2_2_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18519"},{"key":"e_1_2_2_8_1","unstructured":"Jaypirca [Summary of Product Characteristics] [Internet]. Available from:https:\/\/www.ema.europa.eu\/en\/documents\/product\u2010information\/jaypirca\u2010epar\u2010product\u2010information_en.pdf"},{"key":"e_1_2_2_9_1","unstructured":"Jaypirca [Prescribing Information] [Internet]. Indianapolis IN: Eli Lilly and Company; 2023. Available from:https:\/\/pi.lilly.com\/us\/jaypirca\u2010uspi.pdf"},{"key":"e_1_2_2_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(21)00224\u20105"},{"key":"e_1_2_2_11_1","unstructured":"CohenJB ShahNN JurczakW ZinzaniPL CheahCY EyreTA et\u00a0al.981 Pirtobrutinib in relapsed\/refractory (R\/R) mantle cell lymphoma (MCL) patients with prior cBTKi: safety and efficacy including high\u2010risk subgroup analyses from the phase 1\/2 BRUIN study. American Society of Hematology Annual Meeting & Exposition 2023.https:\/\/ash.confex.com\/ash\/2023\/webprogram\/Paper181627.html"},{"key":"e_1_2_2_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000971244.45636.b5"},{"key":"e_1_2_2_13_1","unstructured":"PhillippoDM AdesAE DiasS PalmerS AbramsKR WeltonN et\u00a0al.NICE DSU Technical Support Document 18: Methods for Population\u2010Adjusted Indirect Comparisons in Submission to NICE [Internet]. December 2016. Available from:https:\/\/www.sheffield.ac.uk\/nice\u2010dsu\/tsds\/population\u2010adjusted"},{"key":"e_1_2_2_14_1","unstructured":"European Medicines Agency.Orphan Maintenance Assessment Report. Jaypirca (pirtobrutinib). Treatment of Mantle Cell Lymphoma. EU\/3\/21\/2450 [Internet]. 30 October 2023. Available from:https:\/\/www.ema.europa.eu\/en\/documents\/orphan\u2010maintenance\u2010report\/jaypirca\u2010epar\u2010orphan\u2010maintenance\u2010assessment\u2010report\u2010initial\u2010authorisation_en.pdf"},{"key":"e_1_2_2_15_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2023.2268228"},{"key":"e_1_2_2_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0000000000000509"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.70237","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bjh.70237","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.70237","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T02:20:21Z","timestamp":1771035621000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bjh.70237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1111\/bjh.70237"],"URL":"https:\/\/doi.org\/10.1111\/bjh.70237","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"2025-05-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}